← All diseases
Cancer
Lung cancer (small cell)
Do you want to receive a message when there is new research about Small Cell Lung Cancer (SCLC)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you see one sentence explaining what was studied — and you'll be notified as soon as there is new research about Small cell lung cancer. View what Premium costs.
Publications and studies (3295)
- Development of a competitive enzyme-linked immunosorbent assay for therapeutic drug monitoring of afatinib. (2019/02/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Safety issues with the ALK inhibitors in the treatment of NSCLC: A systematic review. (2019/02/01) ♡
- Contact of a tumour with the pleura is not associated with regional recurrence following stereotactic ablative radiotherapy for early stage non-small cell lung cancer. (2019/02/01) ♡
- Stereotactic ablative radiation therapy versus conventionally fractionated radiation therapy for stage I small cell lung cancer. (2019/02/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer. (2019/02/01) ♡
- Addition of chemotherapy improves overall survival in patients with T2N0M0 non-small cell lung cancer undergoing definitive radiation therapy: An analysis of the SEER database. (2019/02/01) ♡
- Immune Cell Composition in Human Non-small Cell Lung Cancer. (2019/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunological Agents Used in Cancer Treatment. (2019/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer. (2019/02/01) ♡
- 1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase. (2019/01/15) ♡
- Liquid crystalline assembly for potential combinatorial chemo-herbal drug delivery to lung cancer cells. (2019/01/11) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines. (2019/01/10) ♡
- Investigation on Advanced Non-Small-Cell Lung Cancer among Elderly Patients Treated with Chinese Herbal Medicine versus Chemotherapy: A Pooled Analysis of Individual Data. (2019/01/02) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pembrolizumab in Recurrent Squamous Cell Carcinoma of the Vulva: Case Report and Review of the Literature. (2019/01/01) ♡
- FAACT-Anorexia Cachexia Scale: Cutoff Value for Anorexia Diagnosis in Advanced Non-Small Cell Lung Cancer Patients. (2019/01/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. A Pilot Study of Amino Acids in Unresectable Non-Small-Cell Lung Cancer Patients During Chemotherapy: A Randomized Serial N-of-1 Trials Design. (2019/01/01) ♡
- Long-Term Prognostic Impact of Severe Postoperative Complications After Lung Cancer Surgery. (2019/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. S6K2 promises an important therapeutic potential for cancer. (2019/01/01) ♡
- Orthopedia homeobox protein (OTP) is a sensitive and specific marker for primary pulmonary carcinoid tumors in cytologic and surgical specimens. (2019/01/01) ♡
- Photo-controlled release of paclitaxel and model drugs from RNA pyramids. (2019/01/01) ♡
- Scutellaria Radix Promotes Apoptosis in Non-Small Cell Lung Cancer Cells via Induction of AMPK-Dependent Autophagy. (2019/01/01) ♡
- Quercetin is the Active Component of Yang-Yin-Qing-Fei-Tang to Induce Apoptosis in Non-Small Cell Lung Cancer. (2019/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. How Ginsenosides Trigger Apoptosis in Human Lung Adenocarcinoma Cells. (2019/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non-Small Cell Lung Cancer. (2019/01/01) ♡
- Feasibility study of metabolically supported chemotherapy with weekly carboplatin/paclitaxel combined with ketogenic diet, hyperthermia and hyperbaric oxygen therapy in metastatic non-small cell lung cancer. (2019/01/01) ♡
- Chyle test is not a valuable laboratory index in identifying chylothorax after pulmonary resection and lymph node dissection for primary non-small cell lung cancer. (2019/01/01) ♡
- Can Nutritional Status Predict Overall Survival in Patients with Advanced Non-Small Cell Lung Cancer? (2019/01/01) ♡
- Screening of key genes and prediction of therapeutic agents in Arsenic-induced lung carcinoma. (2019/01/01) ♡
- Modified Glasgow Prognostic Score as a Prognostic Factor in Patients with Extensive Disease-Small-Cell Lung Cancer: A Retrospective Study in a Single Institute. (2019/01/01) ♡
- Lean Body Mass and Endocrine Status But Not Age Are Determinants of Resting Energy Expenditure in Patients with Non-Small Cell Lung Cancer. (2019/01/01) ♡
- Long-term results of sleeve lobectomy with continuous suture technique in non-small cell lung cancer. (2019/01/01) ♡
- The Frequency of EGFR and KRAS Mutations in the Turkish Population with Non-small Cell Lung Cancer and their Response to Erlotinib Therapy. (2018/12/31) ♡
- Early Intensive Nutrition Intervention with Dietary Counseling and Oral Nutrition Supplement Prevents Weight Loss in Patients with Advanced Lung Cancer Receiving Chemotherapy: A Clinical Prospective Study. (2018/12/27) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Abscopal Effect after Radiosurgery for Solitary Brain Metastasis from Non-small Cell Lung Cancer. (2018/12/26) ♡
- NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway. (2018/12/25) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Lung stereotactic body radiotherapy after past ablative therapy: a single institution case series. (2018/12/21) ♡
- Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients. (2018/12/19) ♡
- Transcriptome Analysis of Phycocyanin-Mediated Inhibitory Functions on Non-Small Cell Lung Cancer A549 Cell Growth. (2018/12/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case report of primary cardiac sarcoma: a diagnostic and therapeutic challenge. (2018/12/07) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach. (2018/12/04) ♡
- Baohuoside-I suppresses cell proliferation and migration by up-regulating miR-144 in melanoma. (2018/12/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Banxia Xiexin Decoction Is Effective to Prevent and Control Irinotecan-Induced Delayed Diarrhea in Recurrent Small Cell Lung Cancer. (2018/12/01) ♡
- An-te-xiao capsule inhibits tumor growth in non-small cell lung cancer by targeting angiogenesis. (2018/12/01) ♡
- Gambogic acid-induced autophagy in nonsmall cell lung cancer NCI-H441 cells through a reactive oxygen species pathway. (2018/12/01) ♡
- Beneficial effect of additional treatment with widely available anticancer agents in advanced small lung cell carcinoma: A case report. (2018/12/01) ♡
- EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells. (2018/12/01) ♡
- Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients. (2018/12/01) ♡
- p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma. (2018/12/01) ♡
- Prediagnosis weight loss, a stronger factor than BMI, to predict survival in patients with lung cancer. (2018/12/01) ♡
- miR-27a is highly expressed in H1650 cancer stem cells and regulates proliferation, migration, and invasion. (2018/12/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.